ALG advises Morgan Stanley in Abbvie acquisition of Allergan

A&L Goodbody is pleased to be acting for AbbVie's lead financial advisor and lender Morgan Stanley, in connection with AbbVie's proposed $63bn acquisition of Allergan. 

As well as being AbbVie's lead financial advisor, Morgan Stanley is the lead arranger in providing funding commitments of US$38bn to AbbVie to fund the acquisition. 

This is the largest and most complex financing of an Irish takeover transaction and a transformative move for both companies. The ALG team is led by Corporate and M&A Partners Alan Casey, Ronan Lyons & Mark Ward and Finance Partner Peter Murray.

Date published: 05 July 2019